FibroBiologics Announces Update On Its Intellectual Property Portfolio
Portfolio Extends Its Lead in Fibroblast Intellectual Property With 170 Issued Patents and 325+ Patents Issued and Pending Portfolio Covers the Therapeutic Use of Fibroblasts Across Multiple Clinical Pathways and the Manufacturing Techniques Used to Produce Them HOUSTON, Nov. 12, 2026...